创伤后头痛与创伤后应激障碍症状共病退伍军人的认知行为治疗:一项随机临床试验
这项单中心三臂随机临床试验纳入193名9·11后美国战斗退伍军人,比较头痛认知行为治疗、认知加工治疗与常规治疗。头痛认知行为治疗在头痛相关残疾和PTSD症状严重度上均优于常规治疗;认知加工治疗改善PTSD症状但不改善头痛残疾。不良事件极少且各组相似。
要点
- 头痛认知行为治疗较常规治疗降低HIT-6评分3.4分(95%CI -5.4至-1.4;P<.01)。
- 头痛认知行为治疗较常规治疗降低PCL-5评分6.5分(95%CI -12.7至-0.3;P=.04)。
- 认知加工治疗较常规治疗降低PCL-5评分8.9分(95%CI -15.9至-1.9;P=.01),但不改善头痛残疾。
核心结论
- 头痛认知行为治疗对退伍军人创伤后头痛相关残疾有效,并对PTSD症状严重度提供有临床意义的改善。
- 认知加工治疗对PTSD症状有效,但对头痛残疾无效。
研究设计与样本
- 单中心、三平行组随机临床试验,结局评估包括治疗后、3个月随访和6个月随访。
- 2015年5月1日至2019年5月30日入组,数据收集于2019年10月10日结束;数据分析时间为2020年1月20日至2022年2月2日。
- 纳入来自多个创伤中心的9·11后美国战斗退伍军人,共193例,均有创伤后头痛与PTSD症状共病。
- 受试者平均(SD)年龄39.7(8.4)岁,男性退伍军人167例(87%)。
主要发现
- 基线头痛相关残疾严重,平均(SD)HIT-6评分为65.8(5.6)分;基线PTSD症状严重,平均(SD)PCL-5评分为48.4(14.2)分。
- 在汇总的治疗后测量中,头痛认知行为治疗组HIT-6评分较常规治疗组低3.4分(95%CI -5.4至-1.4;P<.01)。
- 在汇总的治疗后测量中,认知加工治疗组HIT-6评分较常规治疗组低1.4分(95%CI -3.7至0.8;P=.21)。
- 在汇总的治疗后测量中,头痛认知行为治疗组PCL-5评分较常规治疗组低6.5分(95%CI -12.7至-0.3;P=.04)。
- 在汇总的治疗后测量中,认知加工治疗组PCL-5评分较常规治疗组低8.9分(95%CI -15.9至-1.9;P=.01)。
关键数值与推荐
- 头痛认知行为治疗为8次治疗,认知加工治疗为12次治疗,对照为头痛常规治疗。
- 共同主要结局为6项头痛影响测验(HIT-6)评估的头痛相关残疾和DSM-5 PTSD检查表(PCL-5)评估的PTSD症状严重度,评估时间从治疗完成至治疗后6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Posttraumatic headache is the most disabling complication of mild traumatic brain injury. Posttraumatic stress disorder (PTSD) symptoms are often comorbid with posttraumatic headache, and there are no established treatments for this comorbidity. OBJECTIVE: To compare cognitive behavioral therapies (CBTs) for headache and PTSD with treatment per usual (TPU) for posttraumatic headache attributable to mild traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS: This was a single-site, 3-parallel group, randomized clinical trial with outcomes at posttreatment, 3-month follow-up, and 6-month follow-up. Participants were enrolled from May 1, 2015, through May 30, 2019; data collection ended on October 10, 2019. Post-9/11 US combat veterans from multiple trauma centers were included in the study. Veterans had comorbid posttraumatic headache and PTSD symptoms. Data were analyzed from January 20, 2020, to February 2, 2022. INTERVENTIONS: Patients were randomly assigned to 8 sessions of CBT for headache, 12 sessions of cognitive processing therapy for PTSD, or treatment per usual for headache. MAIN OUTCOMES AND MEASURES: Co-primary outcomes were headache-related disability on the 6-Item Headache Impact Test (HIT-6) and PTSD symptom severity on the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (PCL-5) assessed from treatment completion to 6 months posttreatment. RESULTS: A total of 193 post-9/11 combat veterans (mean [SD] age, 39.7 [8.4] years; 167 male veterans [87%]) were included in the study and reported severe baseline headache-related disability (mean [SD] HIT-6 score, 65.8 [5.6] points) and severe PTSD symptoms (mean [SD] PCL-5 score, 48.4 [14.2] points). For the HIT-6, compared with usual care, patients receiving CBT for headache reported -3.4 (95% CI, -5.4 to -1.4; P < .01) points lower, and patients receiving cognitive processing therapy reported -1.4 (95% CI, -3.7 to 0.8; P = .21) points lower across aggregated posttreatment measurements. For the PCL-5, compared with usual care, patients receiving CBT for headache reported -6.5 (95% CI, -12.7 to -0.3; P = .04) points lower, and patients receiving cognitive processing therapy reported -8.9 (95% CI, -15.9 to -1.9; P = .01) points lower across aggregated posttreatment measurements. Adverse events were minimal and similar across treatment groups. CONCLUSIONS AND RELEVANCE: This randomized clinical trial demonstrated that CBT for headache was efficacious for disability associated with posttraumatic headache in veterans and provided clinically significant improvement in PTSD symptom severity. Cognitive processing therapy was efficacious for PTSD symptoms but not for headache disability. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02419131.
引用
- McGeary DD, Resick PA, Penzien DB, et al. Cognitive Behavioral Therapy for Veterans With Comorbid Posttraumatic Headache and Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA Neurol. 2022. PMID: 35759281. doi:10.1001/jamaneurol.2022.1567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。